Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Anne Lennard.

Newcastle AuthorsTitleYearFull text
Dr Michal Sieniawski
Dr Katrina Wood
Dr Anne Lennard
Author Correction: High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study (Bone Marrow Transplantation, (2019), 54, 3, (465-468), 10.1038/s41409-018-0294-2)2020
Dr Michal Sieniawski
Dr Katrina Wood
Dr Anne Lennard
High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study2019
Dr Anne Lennard
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial2018
Joseph O'Donoghue
Dr Anne Lennard
Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent2017
Dr Anne Lennard
Outcomes with rituximab monotherapy versus r-chop in post-transplant lymphoproliferative disease arising after solid organ transplant: a United Kingdom multicentre study2016
Dr Michal Sieniawski
Dr Anne Lennard
A New and Validated Clinical Prognostic Model (EPI) for Enteropathy-Associated T-cell Lymphoma2015
Dr Anne Lennard
Dr Viney Wadehra
Anaplastic large cell lymphoma in a reconstructed breast using a silicone implant: A UK case report2014
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Anne Lennard
Impact of p53 positive p21 negative phenotype on outcome in CHOP-R treated DLBCL patients2014
Dr Michal Sieniawski
Dr Anne Lennard
Enteropathy-Associated T-Cell Lymphoma: Epidemiology, Clinical Features, and Current Treatment Strategies2011
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation2010
Professor Stephen Proctor
Dr Anne Lennard
Professor Graham Jackson
Dr Jennifer Wilkinson
Dr Michal Sieniawski
et al.
The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control2010
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
Aggressive Primary Chemotherapy Plus Autologous Stem Cell Transplantation Improves Outcome for Peripheral T Cell Lymphomas Compared with CHOP-Like Regimens2009
Dr Michal Sieniawski
Dr Jennifer Wilkinson
Dr Anne Lennard
Dr Helen Lucraft
Dr Tryfonia Mainou-Fowler
et al.
Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group.2008
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
Sequential Evaluation of Outcome in Enteropathy Associated T Cell Lymphoma Comparing Standard Therapeutic Approaches - Surgery or CHOP-Like Chemotherapy with a New High Dose Ifosfamide/Methotrexate and Autologous Stem Cell Transplant Regimen: A Prospective Study of Scotland and Newcastle Lymphoma Group2008
Dr Michal Sieniawski
Dr Tryfonia Mainou-Fowler
Dr Jennifer Wilkinson
Dr John Davison
Professor Graham Jackson
et al.
The effect of Diffuse Large B-Cell Lymphoma (DLBCL) treatment regimens on survival: a prospective cohort study [Poster]2008
Dr Anne Lennard
Are we NICE to chronic myeloid leukaemia patients in the northern cancer network?2007
Dr Anne Lennard
Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T-cell lymphoma2007
Dr Michael Griffiths
Dr Anne Lennard
The use of adjunctive leukemia specific therapy to improve outcome in patients with chronic myeloid leukemia transplanted using a reduced intensity conditioning (RIC) regimen2007
Dr Anne Lennard
Optimising the use of arsenic trioxide in 'high risk' acute promyelocytic leukaemia (APL): The UK experience2005
Dr Anne Lennard
Population based assessment of treatment outcomes for gastric non-Hodgkins lymphoma2005
Dr Anne Lennard
Telomere shortening correlates with prognostic score at diagnosis and proceeds rapidly during progression of chronic myeloid leukemia2004
Professor Julie Irving
Professor Stephen O'Brien
Dr Anne Lennard
Lynne Minto
Dr Feng Lin
et al.
Use of Denaturing HPLC for Detection of Mutations in the BCR-ABL Kinase Domain in Patients Resistant to Imatinib2004
Dr Anne Lennard
Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic remission2003
Professor Stephen Proctor
Professor Graham Jackson
Dr Anne Lennard
Dr Brian Angus
Dr Katrina Wood
et al.
Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK)2003
Professor Julie Irving
Professor Stephen O'Brien
Dr Anne Lennard
Dr Feng Lin
Emeritus Professor Andy Hall
et al.
The use of denaturing high-performance liquid chromatography (DHPLC) for the detection of mutations in the bcr-abl oncogene in patients resistant to imatinib2003
Professor Stephen Proctor
Dr Brian Angus
Professor Graham Jackson
Dr Anne Lennard
Dr Penelope Taylor
et al.
A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle Lymphoma Group study (SNLG HD III)2002
Dr Anne Lennard
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: Results of a phase 2 study2002
Dr Anne Lennard
Dr Nicholas Bown
Late-appearing MLL rearrangement arising as a secondary change in adult acute myeloid leukemia2002
Dr John Byrne
Professor Stephen O'Brien
Dr Anne Lennard
Molecular monitoring of complete cytogenetic responders following treatment with imatinib (STI571, Gleevec) for CML: A report from the UKSTI571 study group.2002
Dr Anne Lennard
Dr Angela Galloway
Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients2002
Gavin Cuthbert
Julie Freeman-Edward
Dr Anne Lennard
Professor Stephen O'Brien
Dr Nicholas Bown
et al.
Der(9) deletions and response to STI571(Glivec (R)) treatment in chronic phase CML patients.2001
Dr Anne Lennard
Glivec prior to allografting is safe and not associated with increased transplant-related toxicity.2001
Dr Feng Lin
Professor Stephen O'Brien
Dr Anne Lennard
Response of chronic phase CML patients to STI571 therapy assessd by quantitative real time PCR2001
Dr Anne Lennard
Professor Graham Jackson
Stem cell transplantation2001
Professor Julie Irving
Dr Anne Lennard
Professor Stephen Proctor
Dr Penelope Taylor
Validation of the Hasford score in a demographic study in chronic granulocytic leukaemia2001
Dr Anne Lennard
Enteropathy associated T cell lymphoma. A population based study.2000
Dr Anne Lennard
Professor Graham Jackson
Science, medicine, and the future - Stem cell transplantation2000
Dr Anne Lennard
Management of non-Hodgkin's lymphomas1999
Dr Anne Lennard
Mobilization of Philadelphia-negative peripheral blood progenitor cells with chemotherapy and rhuG-CSF in chronic myelogenous leukaemia patients with a poor response to interferon-alpha1998
Professor Graham Jackson
Dr Penelope Taylor
Dr Anne Lennard
Professor Anne Dickinson
Dr Peter Hamilton
et al.
Single centre experience of allogeneic bone marrow transplantation with GvHD prophylaxis based on cyclosporin alone: March 1983 June 19971998
Dr Sally Coulthard
Dr Anne Lennard
Abnormalities of chromosome band 8p11 in leukemia: Two clinical syndromes can be distinguished on the basis of MOZ involvement1997
Dr Anne Lennard
Haematologists in district general hospitals practise evidence based medicine1997
Professor Graham Jackson
Dr Philip Taylor
Dr David Goff
Dr Anne Lennard
Dr Brian Angus
et al.
High dose ifosfamide in combination with etoposide and epirubicin in the treatment of relapsed/refactory Hodgkin's disease: A report on toxicity and efficacy.1997
Professor Julie Irving
Dr Anne Lennard
Professor Anne Dickinson
Philadelphia evaluations of CD34 populations in chronic granulocytic leukaemia; A comparison of bone marrow and peripheral blood stem cell harvests.1997
Professor Graham Jackson
Dr Anne Lennard
Dr Peter Hamilton
Professor Stephen Proctor
Low frequency of myelodysplasia after autologous bone marrow transplantation1995
Dr Anne Lennard
Dr Brian Angus
Professor Stephen Proctor

Prognostic Significance of Epstein Barr Virus Association in Hodgkins Disease

1994
Professor Graham Jackson
Dr Penelope Taylor
Dr Anne Lennard
Professor Stephen Proctor
Autologous bone marrow transplantation in acute lymphoblastic leukaemia1994
Professor Graham Jackson
Dr Anne Lennard
Dr Penelope Taylor
Dr Peter Carey
Dr Brian Angus
et al.
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission1994
Professor Graham Jackson
Dr Anne Lennard
Dr Penelope Taylor
Professor Stephen Proctor
Rapid onset of chronic granulocytic leukaemia after treatment for Hodgkin's disease1994
Professor Andrew Pearson
John Emslie
Dr Anne Lennard
Emeritus Professor Robert Perry
Peter Crawford
et al.

Cytogenetic abnormalities in a disseminated medulloblastoma

1993
Dr Penelope Taylor
Professor Graham Jackson
Dr Anne Lennard
Dr Helen Lucraft
Professor Stephen Proctor
et al.
Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue1993
Dr Anne Lennard
Dr Penelope Taylor
Professor Graham Jackson
Professor Stephen Proctor
Peripheral blood stem-cell transplantation versus non-cryopreserved autologous bone-marrow transplantation1993
Professor Anne Dickinson
Dr Anne Lennard
Dr Rosalind Cartner
Professor Stephen Proctor
Interleukin-2 induction of lymphokine-activated killer activity in the peripheral blood of an acute lymphoblastic leukaemia patient - case study1992
Dr Anne Lennard

All Oral Chemotherapy in Refratory Hodgkins Disease

1991
Dr Anne Lennard
Professor Graham Jackson
Dr Peter Carey
Dr Peter Middleton
Professor Stephen Proctor
et al.
Secondary acute lymphoblastic leukaemia with 4:11 translocation following treatment for Hodgkin's disease1991
Dr Anne Lennard

Vitamin B12 and folate deficiency presenting as leukemia

1990
Dr Anne Lennard
Dr Peter Carey
Professor Graham Jackson
Professor Stephen Proctor
An effective oral combination in advanced relapsed Hodgkin’s disease prednisolone, etoposide, chlorambucil and CCNU1990
Professor Graham Jackson
Dr Jonathan Wallis
Dr Anne Lennard
Professor Stephen Proctor
Hydroxyurea-induced acute alveolitis in a Patient with chronic myeloid leukaemia1990
Dr Anne Lennard
Professor Stephen Proctor
Dr Brian Angus
Dr Helen Lucraft
Lomustine, vindesine and bleomycin (LVB) used in the treatment of relapsed advanced Hodgkin's disease: A prospective study on behalf of the east of Scotland and Newcastle lymphoma group (ESNLG)1989
Professor Stephen Proctor
Dr Roger Finney
Dr Michael Reid
Dr Peter Hamilton
Mehar Afroz Qureshi
et al.
Acute lymphoblastic leukaemia in adults in the northern region of England: A study of 75 cases1985
Dr Anne Lennard
Professor Stephen Proctor
Chronic lymphocytic leukaemia terminating in acute myelofibrosis1984
Dr Peter Hamilton
Dr Anne Lennard
Emeritus Professor Mike Sir Michael Rawlins
The pharmacokinetics of melphalan in patients with multiple myeloma: an intravenous oral study using a conventional dose regimen1983
Professor Thomas Lennard
Dr Anne Lennard

Barium swallow as an aid to preoperative assessment in patients with bronchogenic carcinoma

1982
Dr Peter Hamilton
Dr Anne Lennard
Emeritus Professor Mike Sir Michael Rawlins

Melphalan pharmacokinetics in patients with multiple myeloma: an intravenous and oral study

1982
Professor Thomas Lennard
Dr Anne Lennard

Spontaenous disappearance of psoriasis as presenting feature of oat-cell carcinoma of lung

1980